default author photo

Till Wallrabenstein

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

40

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Immunotherapy with Pembrolizumab Beyond Progression and Local Ablative Therapy in Oligoprogressive Metastatic Non-Small Cell Lung Cancer

Number of pages: 19 Posted: 06 Mar 2025
Anton Oseledchyk, Leopold Häcker, Andreas M. Schmitt, Till Wallrabenstein, Tobias Finazzi, David König and Sacha I. Rothschild
University of Basel - University Hospital Basel, affiliation not provided to SSRN, University of Basel - University Hospital Basel, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Basel - University Hospital Basel and University of Basel - University Hospital Basel
Downloads 40 (1,196,171)

Abstract:

Loading...

NSCLC, oligoprogressive disease, immune checkpoint blockade, PD-1, treatment beyond progression